Literature DB >> 8940004

Aberrant stress-induced phosphorylation of perikaryal neurofilaments.

B I Giasson1, W E Mushynski.   

Abstract

The aberrant phosphorylation of the neurofilament high molecular weight subunit (NFH) in the neuronal perikaryon is a common feature of several neurological diseases. We demonstrated a strong correlation between hyperphosphorylation of the NFH carboxyl-terminal domain and activation of stress-activated protein kinase (SAPK) -gamma in PC12 cells. Agents that activated SAPKgamma in PC12 cells also caused the hyperphosphorylation of perikaryal NFH in cultured dorsal root ganglion neurons. The NFH carboxyl-terminal domain was phosphorylated by SAPKgamma in vitro, and the use of peptide substrates indicated that this event occurred preferentially at KSPXE motifs. We propose that SAPKgamma, perhaps in concert with other SAPKs, is involved in the abnormal phosphorylation of perikaryal NFH. This finding could lead to new insights into the etiology of several neurological diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940004     DOI: 10.1074/jbc.271.48.30404

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation.

Authors:  B S Li; L Zhang; J Gu; N D Amin; H C Pant
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.

Authors:  Ram K Sihag; Masaki Inagaki; Tomoya Yamaguchi; Thomas B Shea; Harish C Pant
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate/early promoter.

Authors:  W Bruening; B Giasson; W Mushynski; H D Durham
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

5.  Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M.

Authors:  N D Amin; N G Ahn; H Jaffe; C A Winters; P Grant; H C Pant
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

6.  Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model.

Authors:  Binukumar Bk; Susan Skuntz; Michaela Prochazkova; Sashi Kesavapany; Niranjana D Amin; Varsha Shukla; Philip Grant; Ashok B Kulkarni; Harish C Pant
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

7.  Axonal Charcot-Marie-Tooth disease and the neurofilament light gene (NF-L)

Authors:  J R Lupski
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

8.  Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia.

Authors:  Clare L Beasley; Andrew J Dwork; Gorazd Rosoklija; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasa Davceva; Andrew R Tait; Suzana K Straus; William G Honer
Journal:  Schizophr Res       Date:  2009-03-09       Impact factor: 4.939

9.  Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein.

Authors:  Parvathi Rudrabhatla; Ya-Li Zheng; Niranjana D Amin; Sashi Kesavapany; Wayne Albers; Harish C Pant
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

10.  The QKI-6 and QKI-7 RNA binding proteins block proliferation and promote Schwann cell myelination.

Authors:  Daniel Larocque; Gabriela Fragoso; Jinghan Huang; Walter E Mushynski; Martin Loignon; Stéphane Richard; Guillermina Almazan
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.